Observational
COVID-19 in Patients with HIV
 

Investigator: Debra Powell, MD

The purpose of his study is to characterize the clinical presentation and course of COVID-19 in patients with HIV.

Learn more about the COVID HIV trial or call the Clinical Trials Office at 484-628-8585.
IMPACC

"Immunophenotyping Assessment in a COVID-19 COHORT"

Investigator: Debra Powell, MD

The purpose of this observational study is to describe the relationship between the body's immune responses and the severity of COVID-19 in patients.

Learn more about the IMPACC trial.

View on NIH.gov and ClinicalTrials.gov

Study is closed to enrollment.
Treatment
ACTIV-4c

(Accelerating COVID-19 Therapeutic Interventions and Vaccines) Post-hospital Thrombosis Prevention Study

Investigator: Daniel Forman, DO

The purpose of this study is to compare the effectiveness and safety of antithrombotic therapy versus no antithrombotic therapy for prevention of symptomatic deep vein thrombosis, pulmonary embolism, ischemic stroke, myocardial infarction (among others) after hospitalization lasting 48 hours or longer for COVID-19.

Learn more about the ACTIV-4c trial.

View on ClinicalTrials.gov, NIH.gov, and CombatCOVID.HHS.gov or call the Clinical Trials Office at 484-628-8585 for more information.
Plasma Adsorption in Patients with Confirmed COVID-19 Infection
 

Investigator: Trudy Demko, MD

The purpose of this study is to evaluate the ability of the D2000 Cartridge, for use with the Spectra Optia Apheresis System, to reduce morbidity and mortality in SARs-CoV-2 infected patients admitted to Intensive Care for management of respiratory failure.

Learn more about the Plasma Adsorption trial.

View on ClinicalTrials.gov and Terumo.com, or call the Clinical Trials Office at 484-628-8585 for more information.